1021 related articles for article (PubMed ID: 26742101)
1. Phosphorylation Regulates the Bound Structure of an Intrinsically Disordered Protein: The p53-TAZ2 Case.
Ithuralde RE; Turjanski AG
PLoS One; 2016; 11(1):e0144284. PubMed ID: 26742101
[TBL] [Abstract][Full Text] [Related]
2. Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein.
Krois AS; Ferreon JC; Martinez-Yamout MA; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1853-62. PubMed ID: 26976603
[TBL] [Abstract][Full Text] [Related]
3. Native Hydrophobic Binding Interactions at the Transition State for Association between the TAZ1 Domain of CBP and the Disordered TAD-STAT2 Are Not a Requirement.
Lindström I; Dogan J
Biochemistry; 2017 Aug; 56(32):4145-4153. PubMed ID: 28707474
[TBL] [Abstract][Full Text] [Related]
4. Complete Coupled Binding-Folding Pathway of the Intrinsically Disordered Transcription Factor Protein Brinker Revealed by Molecular Dynamics Simulations and Markov State Modeling.
Collins AP; Anderson PC
Biochemistry; 2018 Jul; 57(30):4404-4420. PubMed ID: 29990433
[TBL] [Abstract][Full Text] [Related]
5. Conformational propensities of intrinsically disordered proteins influence the mechanism of binding and folding.
Arai M; Sugase K; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9614-9. PubMed ID: 26195786
[TBL] [Abstract][Full Text] [Related]
6. The transient manifold structure of the p53 extreme C-terminal domain: insight into disorder, recognition, and binding promiscuity by molecular dynamics simulations.
Fadda E; Nixon MG
Phys Chem Chem Phys; 2017 Aug; 19(32):21287-21296. PubMed ID: 28597880
[TBL] [Abstract][Full Text] [Related]
7. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.
Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochemistry; 2009 Mar; 48(10):2115-24. PubMed ID: 19220000
[TBL] [Abstract][Full Text] [Related]
8. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.
Jenkins LM; Yamaguchi H; Hayashi R; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Mazur SJ
Biochemistry; 2009 Feb; 48(6):1244-55. PubMed ID: 19166313
[TBL] [Abstract][Full Text] [Related]
9. Anchoring intrinsically disordered proteins to multiple targets: lessons from N-terminus of the p53 protein.
Huang Y; Liu Z
Int J Mol Sci; 2011 Feb; 12(2):1410-30. PubMed ID: 21541066
[TBL] [Abstract][Full Text] [Related]
10. Structural divergence is more extensive than sequence divergence for a family of intrinsically disordered proteins.
Borcherds W; Kashtanov S; Wu H; Daughdrill GW
Proteins; 2013 Oct; 81(10):1686-98. PubMed ID: 23606624
[TBL] [Abstract][Full Text] [Related]
11. Role of electrostatic interactions in binding of peptides and intrinsically disordered proteins to their folded targets. 1. NMR and MD characterization of the complex between the c-Crk N-SH3 domain and the peptide Sos.
Xue Y; Yuwen T; Zhu F; Skrynnikov NR
Biochemistry; 2014 Oct; 53(41):6473-95. PubMed ID: 25207671
[TBL] [Abstract][Full Text] [Related]
12. Residual Structures and Transient Long-Range Interactions of p53 Transactivation Domain: Assessment of Explicit Solvent Protein Force Fields.
Liu X; Chen J
J Chem Theory Comput; 2019 Aug; 15(8):4708-4720. PubMed ID: 31241933
[TBL] [Abstract][Full Text] [Related]
13. Conserved Helix-Flanking Prolines Modulate Intrinsically Disordered Protein:Target Affinity by Altering the Lifetime of the Bound Complex.
Crabtree MD; Borcherds W; Poosapati A; Shammas SL; Daughdrill GW; Clarke J
Biochemistry; 2017 May; 56(18):2379-2384. PubMed ID: 28425697
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the disordered conformational ensembles of the p53 transactivation domain by cancer-associated mutations.
Ganguly D; Chen J
PLoS Comput Biol; 2015 Apr; 11(4):e1004247. PubMed ID: 25897952
[TBL] [Abstract][Full Text] [Related]
15. Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain.
Wells M; Tidow H; Rutherford TJ; Markwick P; Jensen MR; Mylonas E; Svergun DI; Blackledge M; Fersht AR
Proc Natl Acad Sci U S A; 2008 Apr; 105(15):5762-7. PubMed ID: 18391200
[TBL] [Abstract][Full Text] [Related]
16. Folding of an intrinsically disordered protein by phosphorylation as a regulatory switch.
Bah A; Vernon RM; Siddiqui Z; Krzeminski M; Muhandiram R; Zhao C; Sonenberg N; Kay LE; Forman-Kay JD
Nature; 2015 Mar; 519(7541):106-9. PubMed ID: 25533957
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of Coupled Folding-upon-Binding of an Intrinsically Disordered Protein.
Robustelli P; Piana S; Shaw DE
J Am Chem Soc; 2020 Jun; 142(25):11092-11101. PubMed ID: 32323533
[TBL] [Abstract][Full Text] [Related]
18. Long range recognition and selection in IDPs: the interactions of the C-terminus of p53.
Kannan S; Lane DP; Verma CS
Sci Rep; 2016 Mar; 6():23750. PubMed ID: 27030593
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the p300 Taz2-p53 TAD2 complex and comparison with the p300 Taz2-p53 TAD1 complex.
Miller Jenkins LM; Feng H; Durell SR; Tagad HD; Mazur SJ; Tropea JE; Bai Y; Appella E
Biochemistry; 2015 Mar; 54(11):2001-10. PubMed ID: 25753752
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Intrinsically Disordered Protein Function by Post-translational Modifications.
Bah A; Forman-Kay JD
J Biol Chem; 2016 Mar; 291(13):6696-705. PubMed ID: 26851279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
